ENTA Enanta Pharmaceuticals Inc

Price (delayed)

$45.01

Market cap

$932.28M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$5.52

Enterprise value

$908.81M

Enanta is using its robust, chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs for the treatment of viral infections ...

Highlights
The debt has soared by 132% YoY but it has contracted by 7% from the previous quarter
Enanta Pharmaceuticals's quick ratio has decreased by 35% YoY but it has increased by 29% QoQ
ENTA's net income has dropped by 52% year-on-year and by 11% since the previous quarter
The EPS has dropped by 50% year-on-year and by 11% since the previous quarter

Key stats

What are the main financial stats of ENTA
Market
Shares outstanding
20.71M
Market cap
$932.28M
Enterprise value
$908.81M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.58
Price to sales (P/S)
10.1
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
9.93
Earnings
Revenue
$91.56M
EBIT
-$130.55M
EBITDA
-$127.31M
Free cash flow
-$91.04M
Per share
EPS
-$5.52
Free cash flow per share
-$4.43
Book value per share
$17.47
Revenue per share
$4.46
TBVPS
$19.8
Balance sheet
Total assets
$406.82M
Total liabilities
$48.24M
Debt
$18.13M
Equity
$358.58M
Working capital
$311.13M
Liquidity
Debt to equity
0.05
Current ratio
11.12
Quick ratio
9.75
Net debt/EBITDA
0.18
Margins
EBITDA margin
-139%
Gross margin
100%
Net margin
-122.7%
Operating margin
-144%
Efficiency
Return on assets
-25.9%
Return on equity
-28.8%
Return on invested capital
-36.1%
Return on capital employed
-34.7%
Return on sales
-142.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ENTA stock price

How has the Enanta Pharmaceuticals stock price performed over time
Intraday
-1.45%
1 week
10.45%
1 month
14.73%
1 year
-6.5%
YTD
-39.81%
QTD
-36.77%

Financial performance

How have Enanta Pharmaceuticals's revenue and profit performed over time
Revenue
$91.56M
Gross profit
$91.56M
Operating income
-$131.83M
Net income
-$112.33M
Gross margin
100%
Net margin
-122.7%
The operating margin has plunged by 60% YoY and by 4.9% from the previous quarter
The net margin has plunged by 56% YoY and by 13% from the previous quarter
The company's operating income has shrunk by 56% YoY and by 3.2% QoQ
ENTA's net income has dropped by 52% year-on-year and by 11% since the previous quarter

Growth

What is Enanta Pharmaceuticals's growth rate over time

Valuation

What is Enanta Pharmaceuticals stock price valuation
P/E
N/A
P/B
2.58
P/S
10.1
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
9.93
The EPS has dropped by 50% year-on-year and by 11% since the previous quarter
ENTA's P/B is 22% below its last 4 quarters average of 3.3 and 19% below its 5-year quarterly average of 3.2
The equity has decreased by 18% YoY and by 7% from the previous quarter
The price to sales (P/S) is 24% lower than the last 4 quarters average of 13.3 but 7% higher than the 5-year quarterly average of 9.4
Enanta Pharmaceuticals's revenue has decreased by 2.8% YoY

Efficiency

How efficient is Enanta Pharmaceuticals business performance
Enanta Pharmaceuticals's return on equity has shrunk by 78% YoY and by 17% QoQ
ENTA's return on invested capital has dropped by 74% year-on-year and by 4.9% since the previous quarter
Enanta Pharmaceuticals's ROA has plunged by 70% YoY and by 16% from the previous quarter
The return on sales has dropped by 66% year-on-year and by 5% since the previous quarter

Dividends

What is ENTA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ENTA.

Financial health

How did Enanta Pharmaceuticals financials performed over time
The total liabilities has soared by 52% YoY but it has contracted by 14% from the previous quarter
Enanta Pharmaceuticals's quick ratio has decreased by 35% YoY but it has increased by 29% QoQ
The debt is 95% less than the equity
The company's debt to equity has surged by 150% YoY
The debt has soared by 132% YoY but it has contracted by 7% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.